Product NDC: | 0087-2773 |
Proprietary Name: | AVAPRO |
Non Proprietary Name: | IRBESARTAN |
Active Ingredient(s): | 300 mg/1 & nbsp; IRBESARTAN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0087-2773 |
Labeler Name: | Bristol-Myers Squibb Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020757 |
Marketing Category: | NDA |
Start Marketing Date: | 19970930 |
Package NDC: | 0087-2773-94 |
Package Description: | 1 BLISTER PACK in 1 CARTON (0087-2773-94) > 7 TABLET in 1 BLISTER PACK |
NDC Code | 0087-2773-94 |
Proprietary Name | AVAPRO |
Package Description | 1 BLISTER PACK in 1 CARTON (0087-2773-94) > 7 TABLET in 1 BLISTER PACK |
Product NDC | 0087-2773 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | IRBESARTAN |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19970930 |
Marketing Category Name | NDA |
Labeler Name | Bristol-Myers Squibb Company |
Substance Name | IRBESARTAN |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |